EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects

Guiling Chen, Guoping Sheng, Kaiqi Wu, Tinghan Jin, Qi Jiang, Tong Guo, Yifan Chen iD, Hanwei Yin, Guozhou Zhang, Zhenwei Shen, Huihui Zeng

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-12

DOI: 10.2147/dddt.s610536 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Guiling Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, 310022, People's Republic of China. Hauptthemen laut MEDLINE: Organoselenium Compounds, Thioredoxin-Disulfide Reductase, Antifibrotic Agents. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organoselenium CompoundsThioredoxin-Disulfide ReductaseAntifibrotic AgentsAdultFemaleHumansMaleMiddle AgedYoung AdultChinaDose-Response Relationship, DrugDouble-Blind MethodHealthy VolunteersEast Asian People

Stichwörter der Autor:innen

organoseleniumpharmacokineticsphase I trialsafetythioredoxin reductase

Substanzen

Organoselenium CompoundsThioredoxin-Disulfide ReductaseAntifibrotic Agents

Autor:innen und Institutionen

  • Shulan (Hangzhou) Hospital, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, 310022, People's Republic of China.
  • National Human Genetic Resources Center, National Research Institute for Family Planning, Beijing, 100081, People's Republic of China.
  • Shanghai Yuanxi Medicine Corp, Shanghai, 201203, People's Republic of China.

ORCID-Profile: Yifan Chen

Zitieren

APA

Chen, G., Sheng, G., Wu, K., Jin, T., Jiang, Q., Guo, T., Chen, Y., Yin, H., Zhang, G., Shen, Z., & Zeng, H. (2026). Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects. Drug Design, Development and Therapy, Volume 20, 1-12. https://doi.org/10.2147/dddt.s610536

Vancouver

Chen G, Sheng G, Wu K, Jin T, Jiang Q, Guo T, et al. Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects. Drug Design, Development and Therapy. 2026;Volume 20:1-12. doi:10.2147/dddt.s610536

BibTeX
@article{Chen2026,
  author = {Chen, Guiling and Sheng, Guoping and Wu, Kaiqi and Jin, Tinghan and Jiang, Qi and Guo, Tong and Chen, Yifan and Yin, Hanwei and Zhang, Guozhou and Shen, Zhenwei and Zeng, Huihui},
  title = {Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult Subjects},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--12},
  doi = {10.2147/dddt.s610536}
}
Kostenlos starten →